Long-term course of bronchial inflammation and pulmonary function testing in children with postinfectious

Silvija P Jerkic1, Sinem Koc-Günel2, Eva Herrmann3

  • 1Department for Children and Adolescents, Division of Allergy, Pulmonology and Cystic fibrosis, University Hospital, Frankfurt, Germany.

Pediatric Pulmonology
|June 22, 2021
PubMed

Insights

Postinfectious bronchiolitis obliterans (PIBO) causes persistent lung obstruction and inflammation in children, despite continued lung growth. This chronic respiratory condition requires ongoing monitoring for long-term respiratory health.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Chronic Lung Disease

Background:

  • Postinfectious bronchiolitis obliterans (PIBO) is a rare, chronic respiratory condition.
  • It develops after severe lower airway infections in children.

Purpose of the Study:

  • To investigate the long-term bronchial inflammation and pulmonary function in children with PIBO.
  • To assess changes in lung function over time in PIBO patients.

Main Methods:

  • Retrospective analysis of medical charts from 21 children diagnosed with PIBO.
  • Evaluation of 217 pulmonary function tests (PFTs) and 56 sputum analyses over an 8-year period.
  • Assessed FEV1, FVC, FEV1/FVC ratio, and neutrophil counts in sputum.

Main Results:

  • Significant decrease in FEV1 (1.07% per year) and FEV1/FVC ratio (1.44% per year) indicating persistent obstruction.
  • Stable FVC in z-score but significant increase in absolute L/cm height, suggesting continued lung growth.
  • Increased neutrophil percentage in sputum (2.12% per year) indicating persistent pulmonary inflammation.

Conclusions:

  • PIBO leads to significant, persistent pulmonary obstruction over an 8-year follow-up.
  • Children with PIBO experience persistent lung inflammation with increasing neutrophils in sputum.
  • Despite obstruction, lung growth continues, and patients do not show increased susceptibility to respiratory infections.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.5K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
502
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.7K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.2K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.8K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.4K